How To Use HCPCS Code C2639

HCPCS code C2639 describes a brachytherapy source that is non-stranded and contains iodine-125. This code is used to identify the specific type of brachytherapy source that is being used in a medical procedure. In this article, we will explore the details of HCPCS code C2639, including its official description, procedure, when to use it, billing guidelines, historical information, Medicare and insurance coverage, and provide examples of when this code should be billed.

1. What is HCPCS C2639?

HCPCS code C2639 is used to identify a specific type of brachytherapy source that is non-stranded and contains iodine-125. Brachytherapy is a form of radiation therapy where a radioactive source is placed inside or near the tumor to deliver targeted radiation treatment. This code specifically refers to the type of brachytherapy source used in the procedure.

2. Official Description

The official description of HCPCS code C2639 is “Brachytherapy source, non-stranded, iodine-125, per source.” The short description is “Parenteral supp not othrws c.” This description accurately represents the type of brachytherapy source being coded.

3. Procedure

1. The provider begins by preparing the patient for the brachytherapy procedure.
2. A catheter or applicator is inserted into the body, either directly into the tumor or near the tumor site.
3. The brachytherapy source, which contains iodine-125, is then inserted into the catheter or applicator.
4. The source remains in place for a specific amount of time, delivering radiation therapy to the targeted area.
5. After the desired treatment time, the brachytherapy source is removed from the patient’s body.
6. The patient is monitored and may require follow-up appointments to assess the effectiveness of the brachytherapy treatment.

4. When to use HCPCS code C2639

HCPCS code C2639 should be used when documenting and billing for a brachytherapy procedure that utilizes a non-stranded iodine-125 source. It is important to ensure that the specific type of brachytherapy source used matches the description provided by this code. This code is typically used in the context of radiation therapy for cancer treatment.

5. Billing Guidelines and Documentation Requirements

When billing for a procedure using HCPCS code C2639, healthcare providers need to document the details of the brachytherapy procedure, including the specific type of brachytherapy source used (non-stranded iodine-125). It is important to include the duration of the treatment and any relevant information regarding the placement and removal of the source. Proper documentation is essential for accurate billing and reimbursement.

6. Historical Information and Code Maintenance

HCPCS code C2639 was added to the Healthcare Common Procedure Coding System on January 01, 1985. It has an effective date of January 01, 1996. There have been no maintenance actions taken for this code, as indicated by the action code N, which means no maintenance for this code. This code has remained unchanged since its addition to the system.

7. Medicare and Insurance Coverage

HCPCS code C2639 is covered by Medicare and other insurance carriers. The pricing indicator code for this code is 57, which indicates that it is priced by other carriers. The multiple pricing indicator code is A, which means it is not applicable as HCPCS priced under one methodology. Medicare and other insurance carriers may have specific coverage guidelines and reimbursement rates for procedures using this code. It is important to verify coverage and reimbursement policies with the respective payers.

8. Examples

Here are five examples of when HCPCS code C2639 should be billed:

1. A patient with prostate cancer undergoes brachytherapy using a non-stranded iodine-125 source.
2. A patient with cervical cancer receives brachytherapy treatment with a non-stranded iodine-125 source.
3. A patient with breast cancer undergoes brachytherapy using a non-stranded iodine-125 source.
4. A patient with lung cancer receives brachytherapy treatment with a non-stranded iodine-125 source.
5. A patient with head and neck cancer undergoes brachytherapy using a non-stranded iodine-125 source.